scorecardresearch
Thursday, September 11, 2025
TopicAstraZeneca

Topic: AstraZeneca

AstraZeneca vaccine has no adverse impact on pregnancy or fertility, study in Lancet says

In the study spanning UK, Brazil and South Africa, the rate of miscarriage was roughly the same between vaccine and placebo groups, & no still births or neonatal deaths were recorded.

AstraZeneca antibody cocktail prevents Covid in high-risk groups, study finds

AstraZeneca said it is preparing to submit the data to regulators for potential emergency-use authorisation. Its findings may also salvage a deal with the US to purchase the drug.

AstraZeneca to apply for Covid vaccine approval in US later this year

The vaccine, which is being produced as Covishield in India, is approved for use by the UK and European medicines regulators but is pending USFDA application.

Animal trials suggest intranasal version of AstraZeneca shot may prevent Covid transmission

Currently tested on animals, researchers now intend to test the effectiveness of intranasal vaccines, in both preventing infection and lowering viral shedding in humans.

Countries using AstraZeneca, Chinese vaccines are considering boosters for Delta protection

Growing concern that Covid-19 vaccines being deployed across much of the developing world aren’t capable of thwarting the delta variant is prompting some countries...

Mixing Astra and Pfizer shots creates strong immune response, Oxford study shows

A mixed schedule of the Pfizer shot followed by Astra vaccine, and vice versa, resulted in high concentrations of antibodies against Covid when given 4 weeks apart, researchers said.

AstraZeneca vaccine could be less effective against Delta variant: Scotland study in Lancet

The study by Scotland researchers found that the risk of hospital admission was approximately double in Covid patients with the Delta variant, compared to those with the Alpha strain.

AstraZeneca vaccine’s chief investigator backs 12-16 week Covishield dose gap in India

Professor Andrew Pollard said that the level of protection provided by one dose of the vaccine significantly increases in the second and third months after the jab.

Pfizer, AstraZeneca vaccines provide ‘good protection’ against Delta variant: Lancet study

The study finds Pfizer's Covid vaccine offers 79 per cent protection and the AstraZeneca vaccine, known as Covishield in India, secures 60 per cent protection against Covid strain.

AstraZeneca vaccine linked to slightly higher risk of low platelet count, study says

The study, published in the journal Nature Medicine, says Oxford-AstraZeneca vaccine carries a slightly increased risk of a drop in platelet count and blood clots in arteries.

On Camera

Lifting night shift ban increased female employment in India—only among big firms

Discriminatory laws limit firms from hiring willing women, and removing such barriers can help narrow the economic gap between developing and developed countries.

What’s behind bond yields’ logic-defying spike? The market’s concern over the future

While bond yields tend to fall amid low inflation & interest rate cuts, market experts say they’ve been rising due to concerns over tax collections, fiscal deficit & potential impact of US tariffs.

‘Foreign policy rests on hard power’—from 1965 Indo-Pak war to Op Sindoor, key takeaways for India

A panel of experts moderated by ThePrint’s Editor-in-Chief Shekhar Gupta drew connections between insights of 1965 Indo-Pak War and strategic takeaways highlighted by Op Sindoor.

Punjab is fast becoming the new Northeast. And there’s a message in it for Modi

In its toughest time in decades because of floods, Punjab would’ve expected PM Modi to visit. If he has the time for a Bihar tour, why not a short visit to next-door Punjab?